ETON News and Press, Eton Pharmaceutcials Inc. From 07/08/25

- NDA assigned a Target Action Date of February 25, 2026 - - Product has patent protection through 2044 - DEER PARK, Ill., July 08, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company f...

2025-07-01 11:00:07 ET Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is the focus of IBN’s latest stock spotlight. The company’s shares have moved -5.19% on the day to $13.51. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commerc...

2025-06-27 07:12:13 ET More on Eton Pharmaceuticals Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside Eton Pharmaceuticals Set To Dominate Orphan Drug Niche Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript ...

DEER PARK, Ill., June 27, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will be added to ...

2025-06-25 11:05:49 ET Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is the focus of IBN’s latest stock spotlight. The company’s shares have moved -2.21% on the day to $13.29. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commerc...

2025-06-16 10:33:36 ET Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is the focus of IBN’s latest stock spotlight. The company’s shares have moved 2.76% on the day to $14.7. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercia...

2025-06-09 20:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-06-06 17:26:17 ET ... Read the full article on Seeking Alpha For further details see: Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside

2025-06-03 10:41:44 ET Eton Pharmaceuticals, Inc. (NASDAQ: ETON) is the focus of IBN’s latest stock spotlight. The company’s shares have moved -6.13% on the day to $17.68. Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commerc...

2025-05-29 08:23:46 ET More on Eton Pharmaceuticals Eton Pharmaceuticals Set To Dominate Orphan Drug Niche Eton Pharmaceuticals, Inc. (ETON) Q1 2025 Earnings Call Transcript Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call Transcript ...